Form 8-K - Current report:
SEC Accession No. 0000914475-25-000139
Filing Date
2025-05-30
Accepted
2025-05-30 16:05:10
Documents
21
Period of Report
2025-05-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nbix-20250530.htm   iXBRL 8-K 24678
2 EX-10.1 exhibit101.htm EX-10.1 84901
6 GRAPHIC exhibit101001.jpg GRAPHIC 1017087
7 GRAPHIC exhibit101002.jpg GRAPHIC 1169374
8 GRAPHIC exhibit101003.jpg GRAPHIC 1276209
9 GRAPHIC exhibit101004.jpg GRAPHIC 1049521
10 GRAPHIC exhibit101005.jpg GRAPHIC 1022798
11 GRAPHIC exhibit101006.jpg GRAPHIC 718323
12 GRAPHIC exhibit101007.jpg GRAPHIC 572197
13 nbix-20250530_g1.jpg GRAPHIC 18386
  Complete submission text file 0000914475-25-000139.txt   9706699

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20250530.xsd EX-101.SCH 1791
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20250530_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20250530_pre.xml EX-101.PRE 12514
23 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20250530_htm.xml XML 2716
Mailing Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 251010782
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)